Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$718K Sell
4,635
-51
-1% -$7.43K 0.34% 62
2023
Q3
$698K Buy
4,686
+1,500
+47% +$220K 0.15% 72
2023
Q2
$429K Hold
3,186
0.09% 78
2023
Q1
$508K Sell
3,186
-2,775
-47% -$424K 0.12% 71
2022
Q4
$963K Sell
5,961
-175
-3% -$26.8K 0.22% 65
2022
Q3
$824K Sell
6,136
-550
-8% -$78.9K 0.37% 62
2022
Q2
$1.02M Buy
6,686
+4,100
+159% +$626K 0.24% 58
2022
Q1
$419K Buy
+2,586
New +$376K 0.08% 69

Other funds holding ABBV

Evelyn V. Moreno's ABBV Position: Q4 2023 in Review

Evelyn V. Moreno reduced its AbbVie (ABBV) stake by 1.1% in Q4 2023, selling an estimated $7.43K and leaving 4,635 shares worth $718K. The position accounts for 0.34% of the portfolio, ranked #62.

Evelyn V. Moreno first reported a position in ABBV in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.02M in Q2 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Evelyn V. Moreno held 4,635 shares of AbbVie worth $718K as of Q4 2023.
  • Evelyn V. Moreno sold 51 AbbVie shares in Q4 2023, an estimated $7.43K.
  • AbbVie made up 0.34% of Evelyn V. Moreno's portfolio in Q4 2023, its #62 holding.
  • Evelyn V. Moreno first reported a position in AbbVie in Q1 2022 and has held it in 8 quarters since.
  • Evelyn V. Moreno's AbbVie position peaked at $1.02M in Q2 2022.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Evelyn V. Moreno's 13F filing for Q4 2023, filed 9 Feb 2024.